Home > Boards > US Listed > Biotechs > NantKwest (NK)

I am new to trading since December but

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
stocktrademan Member Profile
 
Followed By 448
Posts 9,841
Boards Moderated 1
Alias Born 04/28/14
160x600 placeholder
NantKwest Launches First-in-class, First-in-human Phase I Clinical Trial With a Targeted PD-L1 t-haNK Cell Therapy in Patient... Business Wire - 6/24/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/10/2019 4:04:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:48:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:45:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:42:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:40:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/7/2019 4:36:37 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/7/2019 4:32:37 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 4:07:44 PM
Cheryl Cohen Appointed to NantKwest’s Board of Directors Business Wire - 6/6/2019 4:10:00 PM
NantKwest Announces Durable Complete Responses in Multiple Advanced-Stage Solid Tumor Cancers Following Off-the-Shelf NK Cell... Business Wire - 6/4/2019 8:00:00 AM
NantKwest Announces Updated Clinical Results for Nanatinostat (VRx-3996), a Novel HDAC Inhibitor Being Developed in Partnersh... Business Wire - 6/4/2019 7:45:00 AM
NantKwest Launches First-in-Human Targeted NK Phase I Clinical Trial of CD19 T-haNK Cell Therapy in Lymphoma Patients Business Wire - 6/3/2019 2:50:00 PM
NantKwest to Present and Provide Update at Upcoming Jefferies 2019 Annual Healthcare Conference Business Wire - 6/3/2019 8:00:00 AM
NantKwest, NantCell & NantOmics to Provide Updated Preclinical & Clinical Data in Four Abstracts at Part of the American Soci... Business Wire - 5/31/2019 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 4:10:11 PM
Brink Biologics Announces Research License Agreement with Worcester Polytechnic Institute for Use of NantKwest’s NK-92®... Business Wire - 5/1/2019 8:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/26/2019 4:13:38 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 4/1/2019 4:09:04 PM
NantKwest Announces New haNK Natural Killer Cell Patent Issuance Further Expanding Intellectual Property Estate Business Wire - 4/1/2019 8:00:00 AM
NantKwest Chairman & CEO Dr. Patrick Soon-Shiong Exercises $39 Million in Warrants & Options in Support of NK’s Natural Kil... Business Wire - 3/25/2019 8:00:00 AM
NantKwest Chairman & CEO Dr. Patrick Soon-Shiong to Present Vision for Next Generation Natural Killer Cell Therapies During K... Business Wire - 3/18/2019 5:00:00 AM
Annual Report (10-k) Edgar (US Regulatory) - 3/13/2019 4:09:58 PM
NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Target... Business Wire - 3/4/2019 8:00:00 AM
NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple Combination of off-the-Shelf Natura... Business Wire - 1/9/2019 8:00:00 AM
stocktrademan   Wednesday, 06/14/17 11:48:11 AM
Re: kwisatzhaderach post# 1138
Post # of 1169 
Quote:
I am new to trading since December but based on my limited knowledge of studying stocks I believe this one can hit 7.77 relatively soon



I think that is certainly possible. Whenever the rsi breaks out above its own resistance levels (not just the price) that is a very good sign of continued moves higher. Currently the weekly rsi is breaking out and it has a lot of room to run until it gets to the upper boundary overbought area. There might be some chart disturbances or pullbacks for a few days but the long term investing trend is intact. In fact the macd is making higher lows while the price makes lower lows, and this is bullish divergence. The price just went above the 50 moving average as well so this is positive.



Would recommend reading just about everything at Stockchart.com's chart school and try out the new ideas and things that make sense. Try to trade a new way on paper for a month or so, or at least go back on various charts and see if a profit can be made after 20 trades or so on each chart. Try it in various years to get the chart when the overall market conditions might be different. That will let you know if the method works with you and than can proceed with a small real position.

Stockchart's education section free and has it all. Different people will have different impressions on the articles, but that's how we all find what will work the best for ourselves. Good luck with your trading and continued learning.

http://goo.gl/3cS5OP

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist